World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
44
Citations
6619
World Ranking
4802
National Ranking
2154

Overview

Joshua Miller is affiliated with Northwestern University in the United States. Their research primarily focuses on the fields of Immunology and Microbiology, with additional work in Medicine. Within these areas, their subfield specializations include Immunology and Hematology.

The main topics explored in their research cover several aspects of immune cell biology and transplantation, including:

  • T-cell and B-cell Immunology
  • Hematopoietic Stem Cell Transplantation
  • Immune Cell Function and Interaction

Joshua Miller has contributed to the scholarly literature with publications in established venues such as Frontiers in Immunology. Their recent work includes a 2024 research article titled Differentiation of regulatory myeloid and T-cells from adult human hematopoietic stem cells after allogeneic stimulation, published in Frontiers in Immunology.

Their research collaborations feature recurrent co-authorship with several colleagues, including:

  • James M. Mathew
  • Jes M. Sanders
  • Robert Cirocco
  • Joseph R. Leventhal

Joshua Miller's contributions to the understanding of immune regulation involve investigation of how different immune cell populations arise and interact following hematopoietic stem cell transplantation. The focus on regulatory myeloid and T-cell differentiation highlights themes relevant to transplantation immunology and tolerance induction.

Best Publications

  • Chimerism and Tolerance Without GVHD or Engraftment Syndrome in HLA-Mismatched Combined Kidney and Hematopoietic Stem Cell Transplantation

    Joseph Leventhal;Michael Abecassis;Joshua Miller;Lorenzo Gallon

  • Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure.

    Kazuo Mizutani;Paul Terasaki;Anne Rosen;Violet Esquenazi

  • Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.

    Sumihito Tamura;Tomoaki Kato;Mariana Berho;Evangelos P. Misiakos

  • A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring.

    Gaetano Ciancio;George W. Burke;Jeffrey J. Gaynor;Manuel R. Carreno

  • Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings

    Keith Zucker;Anne Rosen;Alexandra Tsaroucha;Ludmilla de Faria

  • The impact of hepatitis C virus infection on renal allograft recipients

    David Roth;Keith Zucker;Robert Cirocco;Angelo M DeMattos

  • High-dose donor bone marrow infusions to enhance allograft survival : The effect of timing

    Camillo Ricordi;Theodore Karatzas;Jose Nery;Marc Webb

  • The Importance of Anti-HLA-Specific Antibody Strength in Monitoring Kidney Transplant Patients

    K. Mizutani;P. Terasaki;E. Hamdani;V. Esquenazi

  • Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome.

    Joseph Leventhal;Michael Abecassis;Joshua Miller;Lorenzo Gallon

  • Six-year clinical effect of donor bone marrow infusions in renal transplant patients.

    Gaetano Ciancio;Joshua Miller;Joshua Miller;Rolando O. Garcia-Morales;Manuel Carreno

  • De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients.

    David Roth;Robert Cirocco;Keith Zucker;Phillip Ruiz

  • Soluble HLA‐G Expression and Renal Graft Acceptance

    J. Qiu;P. I. Terasaki;J. Miller;K. Mizutani

  • A prospective study of hepatitis C virus infection in renal allograft recipients.

    David Roth;Keith Zucker;Robert Cirocco;George Burke

  • Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants.

    Joseph R. Leventhal;Mary J. Elliott;Esma S. Yolcu;Larry D. Bozulic

  • Mycophenolate mofetil in cadaveric renal transplantation

    S. Cho;G. Danovitch;M. Deierhoi;R. Ferguson

  • A randomized long-term trial of tacrolimus/sirolimus versus tacrolimums/mycophenolate versus cyclosporine/sirolimus in renal transplantation: three-year analysis.

    Gaetano Ciancio;George W. Burke;Jeffrey J. Gaynor;Phillip Ruiz

  • The Role of Donor Bone Marrow Infusions in Withdrawal of Immunosuppression in Adult Liver Allotransplantation

    Panagiotis Tryphonopoulos;Andreas G. Tzakis;Debbie Weppler;Rolando Garcia-Morales

  • The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.

    Rolando Garcia-Morales;Manuel Carreno;James Mathew;Keith Zucker

  • Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation

    Xaralambos Zervos;Deborah Weppler;Georgios Fragulidis;Maria Torres

  • A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow-up

    Gaetano Ciancio;George W. Burke;Jeffrey J. Gaynor;David Roth

  • Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation.

    Andreas G. Tzakis;Tomoaki Kato;Seigo Nishida;David M. Levi

  • Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients.

    David Roth;Jane Colona;George W. Burke;Gaetano Ciancio

  • Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients

    Rolando Garcia-Morales;Manuel Carreno;James Mathew;Robert Cirocco

  • Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass model.

    Dora M. Berman;Over Cabrera;Over Cabrera;Norman M. Kenyon;Joshua Miller

  • Allosensitization of islet allograft recipients.

    Roberta Cardani;Roberta Cardani;Antonello Pileggi;Camillo Ricordi;Carmen Gomez

  • Use of older controlled non-heart-beating donors for liver transplantation.

    Tatsuya Fukumori;Tatsuya Fukumori;Tomoaki Kato;David Levi;Les Olson

  • Detection of antibody to hepatitis C virus in renal transplant recipients.

    David Roth;John A. Fernandez;George W. Burke;Violet Esquenazi

  • Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.

    Lorenzo Gallon;Opas Traitanon;Yuming Yu;Bo Shi

  • The human bone marrow as an immunoregulatory organ.

    Joshua Miller;James Mathew;Rolando Garcia-Morales;Keith E. Zucker

Frequent Co-Authors

Andreas G. Tzakis
Andreas G. Tzakis Cleveland Clinic
David Roth
David Roth University of Miami
Camillo Ricordi
Camillo Ricordi University of Miami
Michael Abecassis
Michael Abecassis University of Arizona
David M. Roth
David M. Roth University of California San Diego
Phillip Ruiz
Phillip Ruiz University of Miami
Eugene R. Schiff
Eugene R. Schiff University of Miami
Suzanne T. Ildstad
Suzanne T. Ildstad University of Louisville
Christopher M. Gomez
Christopher M. Gomez University of Chicago
Bonnie B. Blomberg
Bonnie B. Blomberg University of Miami

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology opens doors to various healthcare roles, many of which benefit from specialized nursing education and certifications. For those already in nursing, advancing your qualifications with an acute care certification for FNP can be a strategic move, enabling you to work with patients facing complex immunological conditions in critical care settings.

If you're looking to fast-track your nursing education, accelerated NP programs offer an efficient pathway to becoming a nurse practitioner with expertise that complements immunology. For individuals without a nursing background, there are excellent online nursing programs for non nurses that provide the foundational knowledge needed to enter nursing and eventually specialize.

Additionally, if you're searching for accessible entry points into nursing, consider ABSN programs with high acceptance rates. These programs help aspiring nurses quickly obtain their Bachelor of Science in Nursing, an important step toward careers involving immunology research and patient care.

By exploring these educational routes, students and professionals can tailor their career paths to meet the evolving demands of immunology and related healthcare fields.

Best Scientists Citing Joshua Miller

Trending Scientists

Recently Published Articles